Clinical Staging in Multiple Myeloma
Authors:
- 1 June 1979
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 42 (2) , 199-205
Abstract
Summary. Analysis of 237 patients with myeloma, retrospectively classified according to the staging system proposed by Durie and Salmon, showed highly significant differences (P < 0.0001) in the survival of patients with low, intermediate and high tumour cell masses (Stages I, II and III respectively). The median survival for Stage I patients was 64 months, Stage II 32 months, and Stage III 6 months. The median survival of patients presenting with renal impairment was only 2 months, compared to 21 months for those presenting with normal renal function (P < 0.0001). The use of this clinical staging system, which is based on myeloma protein synthesis rates and the calculation of total body tumour cell mass, should be considered in planning future trials of therapy in this disease.Keywords
This publication has 9 references indexed in Scilit:
- Multiple myeloma: quantitative staging and assessment of response with a programmable pocket calculatorBlood, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Prognostic factors in multiple myelomaCancer, 1975
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Melphalan and prednisone: An effective combination for the treatment of multiple myelomaThe American Journal of Medicine, 1973
- PART I. ANALYSIS OF PRESENTING FEATURES OF PROGNOSTIC IMPORTANCEBritish Journal of Haematology, 1973
- Immunoglobulin synthesis and total body tumor cell number in IgG multiple myelomaJournal of Clinical Investigation, 1970
- “Sandwich” Solid Phase Radioimmunoassay for the Quantitative Deteriminaton of Human ImmunoglobulinsThe Journal of Immunology, 1969
- Plasmacytic myelomaThe American Journal of Medicine, 1967